23andMe to buy online pharmacy Lemonaid for $400M
The company plans to pair its direct-to-consumer genetic testing with Lemonaid’s online coaching and prescription delivery. It plans to buy the company for $400 million in stock and cash.
This is the startup enabling fast-growing mail-order prescription drug brands
Behind companies like Hims, Nurx and Lemonaid sits Truepill's technology, which handles the logistics, shipping and pharmacy fulfillment necessary to run the direct-to-consumer businesses.
presented by
Price Transparency is the New North in the PBM World
In this episode hear how improving benefit verification, prior authorizations, and patient affordability with smart integrations and real-time eligibility can streamline healthcare workflows.